173 related articles for article (PubMed ID: 37210448)
1. Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer.
Augustinus S; Schafrat PJM; Janssen BV; Bonsing BA; Brosens LAA; Busch OR; Crobach S; Doukas M; van Eijck CH; van der Geest LGM; Groot Koerkamp B; de Hingh IHJT; Raicu GM; van Santvoort HC; van Velthuysen ML; Verheij J; Besselink MG; Farina Sarasqueta A;
Ann Surg Oncol; 2023 Aug; 30(8):5051-5060. PubMed ID: 37210448
[TBL] [Abstract][Full Text] [Related]
2. Surgery for pancreatic cancer: current controversies and challenges.
Karunakaran M; Barreto SG
Future Oncol; 2021 Dec; 17(36):5135-5162. PubMed ID: 34747183
[TBL] [Abstract][Full Text] [Related]
3. Impact of centralization of pancreatoduodenectomy on reported radical resections rates in a nationwide pathology database.
Onete VG; Besselink MG; Salsbach CM; Van Eijck CH; Busch OR; Gouma DJ; de Hingh IH; Sieders E; Dejong CH; Offerhaus JG; Molenaar IQ;
HPB (Oxford); 2015 Aug; 17(8):736-42. PubMed ID: 26037776
[TBL] [Abstract][Full Text] [Related]
4. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
Demir IE; Jäger C; Schlitter AM; Konukiewitz B; Stecher L; Schorn S; Tieftrunk E; Scheufele F; Calavrezos L; Schirren R; Esposito I; Weichert W; Friess H; Ceyhan GO
Ann Surg; 2018 Dec; 268(6):1058-1068. PubMed ID: 28692477
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
[TBL] [Abstract][Full Text] [Related]
6. Preparing for prospective clinical trials: a national initiative of an excellence registry for consecutive pancreatic cancer resections.
Gangl O; Sahora K; Kornprat P; Margreiter C; Primavesi F; Bareck E; Schindl M; Längle F; Öfner D; Mischinger HJ; Pratschke J; Gnant M; Függer R
World J Surg; 2014 Feb; 38(2):456-62. PubMed ID: 24121365
[TBL] [Abstract][Full Text] [Related]
7. Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy?: A Multicenter, Randomized, Controlled Trial.
Sabater L; Cugat E; Serrablo A; Suarez-Artacho G; Diez-Valladares L; Santoyo-Santoyo J; Martín-Pérez E; Ausania F; Lopez-Ben S; Jover-Navalon JM; Garcés-Albir M; Garcia-Domingo MI; Serradilla M; Pérez-Aguirre E; Sánchez-Pérez B; Di Martino M; Senra-Del-Rio P; Falgueras-Verdaguer L; Carabias A; Gómez-Mateo MC; Ferrandez A; Dorcaratto D; Muñoz-Forner E; Fondevila C; Padillo J
Ann Surg; 2019 Nov; 270(5):738-746. PubMed ID: 31498183
[TBL] [Abstract][Full Text] [Related]
8. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
9. Impact of centralization of pancreatic cancer surgery on resection rates and survival.
Gooiker GA; Lemmens VE; Besselink MG; Busch OR; Bonsing BA; Molenaar IQ; Tollenaar RA; de Hingh IH; Wouters MW
Br J Surg; 2014 Jul; 101(8):1000-5. PubMed ID: 24844590
[TBL] [Abstract][Full Text] [Related]
10. Perioperative and oncologic outcome of robot-assisted minimally invasive (hybrid laparoscopic and robotic) pancreatoduodenectomy: based on pancreatic fistula risk score and cancer/staging matched comparison with open pancreatoduodenectomy.
Kim HS; Kim H; Kwon W; Han Y; Byun Y; Kang JS; Choi YJ; Jang JY
Surg Endosc; 2021 Apr; 35(4):1675-1681. PubMed ID: 32277354
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis.
Machairas N; Raptis DA; Velázquez PS; Sauvanet A; Rueda de Leon A; Oba A; Koerkamp BG; Lovasik B; Chan C; Yeo CJ; Bassi C; Ferrone CR; Kooby D; Moskal D; Tamburrino D; Yoon DS; Barroso E; de Santibañes E; Kauffmann EF; Vigia E; Robin F; Casciani F; Burdío F; Belfiori G; Malleo G; Lavu H; Hartog H; Hwang HK; Han HS; Marques HP; Poves I; Domínguez-Rosado I; Park JS; Lillemoe KD; Roberts K; Sulpice L; Besselink MG; Abuawwad M; Del Chiaro M; de Santibañes M; Falconi M; D'Silva M; Silva M; Hilal MA; Qadan M; Sell NM; Beghdadi N; Napoli N; Busch ORC; Mazza O; Muiesan P; Müller PC; Ravikumar R; Schulick R; Powell-Brett S; Abbas SH; Mackay TM; Stoop TF; Gallagher TK; Boggi U; van Eijck C; Clavien PA; Conlon KCP; Fusai GK
Ann Surg; 2021 Nov; 274(5):721-728. PubMed ID: 34353988
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Reappraisal of Intraoperative Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Review.
Datta J; Willobee BA; Ryon EL; Shah MM; Drebin JA; Kooby DA; Merchant NB
JAMA Surg; 2021 May; 156(5):489-495. PubMed ID: 33533898
[TBL] [Abstract][Full Text] [Related]
13. Pancreatoduodenectomy with colon resection for cancer: A nationwide retrospective analysis.
Marsman EM; de Rooij T; van Eijck CH; Boerma D; Bonsing BA; van Dam RM; van Dieren S; Erdmann JI; Gerhards MF; de Hingh IH; Kazemier G; Klaase J; Molenaar IQ; Patijn GA; Scheepers JJ; Tanis PJ; Busch OR; Besselink MG;
Surgery; 2016 Jul; 160(1):145-152. PubMed ID: 27059639
[TBL] [Abstract][Full Text] [Related]
14. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers.
Jeon SK; Lee JM; Lee ES; Yu MH; Joo I; Yoon JH; Jang JY; Lee KB; Lee SH
Eur Radiol; 2022 Jan; 32(1):56-66. PubMed ID: 34170366
[TBL] [Abstract][Full Text] [Related]
15. Does center or surgeon volume influence adoption of minimally invasive versus open pancreatoduodenectomy? A systematic review and meta-regression.
Kamarajah SK; Abu Hilal M; White SA
Surgery; 2021 Apr; 169(4):945-953. PubMed ID: 33183790
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancer.
Epelboym I; DiNorcia J; Winner M; Lee MK; Lee JA; Schrope BA; Chabot JA; Allendorf JD
World J Surg; 2014 May; 38(5):1184-95. PubMed ID: 24305935
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant therapy affects margins and margins affect all: perioperative and survival outcomes in resected pancreatic adenocarcinoma.
de Geus SWL; Kasumova GG; Sachs TE; Ng SC; Kent TS; Moser AJ; Vahrmeijer AL; Callery MP; Tseng JF
HPB (Oxford); 2018 Jun; 20(6):573-581. PubMed ID: 29426635
[TBL] [Abstract][Full Text] [Related]
18. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy.
Hue JJ; Sugumar K; Markt SC; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
Surgery; 2021 Jul; 170(1):207-214. PubMed ID: 33454134
[TBL] [Abstract][Full Text] [Related]
19. Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utility.
Pang TC; Wilson O; Argueta MA; Hugh TJ; Chou A; Samra JS; Gill AJ
Pathology; 2014 Apr; 46(3):188-92. PubMed ID: 24614707
[TBL] [Abstract][Full Text] [Related]
20. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Raut CP; Tseng JF; Sun CC; Wang H; Wolff RA; Crane CH; Hwang R; Vauthey JN; Abdalla EK; Lee JE; Pisters PW; Evans DB
Ann Surg; 2007 Jul; 246(1):52-60. PubMed ID: 17592291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
